Clinical trial

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

NCT00123760

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-02-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2004-02-01Date precision: month

Registry last updated2016-02-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Brain Neoplasmsunresolved

Lung Neoplasmsunresolved

Thyroid Neoplasmsunresolved

Colorectal Neoplasmsunresolved

Lymphomaunresolved

Interventions

Positron Emission Tomography (PET) scanPROCEDURE

Sponsors & collaborators

AHS Cancer Control Albertalead sponsor

Cross Cancer Institutecollaborator

Mapped research locations

EdmontonAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00123760 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.